Right‐sided vocal cord paralysis following stereotactic body radiation therapy for non–small‐cell lung cancer: A case report

por Kanaoka, Kensuke, Fukuda, Shoich, Inagaki, Yuji, Taniguchi, Yoshihiko, Nakao, Keiko, Tamiya, Akihiro, Matsuda, Yoshinobu, Okishio, Kyoichi
Publicado 2023

Mediastinal undifferentiated pleomorphic sarcoma with pleural effusion cytopathologically misdiagnosed as epithelial malignant pleural mesothelioma: An autopsy case report

por Matsumoto, Kinnosuke, Nakamura, Yukihiro, Inagaki, Yuji, Taniguchi, Yoshihiko, Tamiya, Akihiro, Matsuda, Yoshinobu, Kasai, Takahiko, Atagi, Shinji
Publicado 2021

Cerebral infarction after treatment with dabrafenib plus trametinib for BRAF‐V600E‐positive non–small cell lung cancer: A case report

por Taniguchi, Yoshihiko, Tamiya, Akihiro, Yanagisawa, Atsushi, Shimaya, Minako, Kawakami, Mayu, Inagaki, Yuji, Saijo, Nobuhiko, Matsuda, Yoshinobu, Okishio, Kyoichi
Publicado 2023

Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib

por Kanaoka, Kensuke, Sumikawa, Hiromitsu, Oyamada, Shunsuke, Tamiya, Akihiro, Inagaki, Yuji, Taniguchi, Yoshihiko, Nakao, Keiko, Matsuda, Yoshinobu, Okishio, Kyoichi
Publicado 2023

Improvement of Mycobacterium abscessus Pulmonary Disease after Nivolumab Administration in a Patient with Advanced Non-small Cell Lung Cancer

por Ishii, Seigo, Tamiya, Akihiro, Taniguchi, Yoshihiko, Tanaka, Tsunehiro, Abe, Yuko, Isa, Shun-ichi, Tsuyuguchi, Kazunari, Suzuki, Katsuhiro, Atagi, Shinji
Publicado 2018

Enhancing tumour content and tumour cell count using microdissection contributes to higher detection rate of genetic mutations by next-generation sequencers()

por Tamiya, Akihiro, Kanaoka, Kensuke, Inagaki, Yuji, Taniguchi, Yoshihiko, Nakao, Keiko, Matsuda, Yoshinobu, Okishio, Kyoichi, Takeda, Maiko, Kasai, Takahiko, Shigeki, Shigeki
Publicado 2023

Predictive factors for progression‐free survival in non‐small cell lung cancer patients receiving nivolumab based on performance status

por Adachi, Yuichi, Tamiya, Akihiro, Taniguchi, Yoshihiko, Enomoto, Takatoshi, Azuma, Kouji, Kouno, Shunichi, Inagaki, Yuji, Saijo, Nobuhiko, Okishio, Kyoichi, Atagi, Shinji
Publicado 2019

The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLC

por Tamiya, Motohiro, Tamiya, Akihiro, Okamoto, Norio, Taniguchi, Yoshihiko, Nishino, Kazumi, Atagi, Shinji, Hirashima, Tomonori, Imamura, Fumio, Kumagai, Toru, Suzuki, Hidekazu
Publicado 2021

Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer

por Matsumoto, Yoshiya, Kawaguchi, Tomoya, Watanabe, Masaru, Isa, Shun-ichi, Ando, Masahiko, Tamiya, Akihiro, Kubo, Akihito, Kitagawa, Chiyoe, Yoshimoto, Naoki, Koh, Yasuhiro
Publicado 2022

Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer

por Kaneda, Toshihiko, Yoshioka, Hiroshige, Tamiya, Motohiro, Tamiya, Akihiro, Hata, Akito, Okada, Asukaka, Niwa, Takashi, Shiroyama, Takayuki, Kanazu, Masaki, Ishida, Tadashi, Katakami, Nobuyuki
Publicado 2018

A High PD-L1 Expression in Pulmonary Pleomorphic Carcinoma Correlates with Parietal-pleural Invasion and Might Predict a Poor Prognosis

por Naito, Maiko, Tamiya, Akihiro, Takeda, Maiko, Taniguchi, Yoshihiko, Saijo, Nobuhiko, Naoki, Yoko, Okishio, Kyoichi, Yoon, Hyungeun, Kasai, Takahiko, Matsumura, Akihide, Atagi, Shinji
Publicado 2018

Poor effect of osimertinib on EGFR exon 20 insertion-positive lung adenocarcinoma: A case report

por Inagaki, Yuji, Tamiya, Akihiro, Matsuda, Yoshinobu, Azuma, Kouji, Adachi, Yuichi, Enomoto, Takatoshi, Kouno, Shunichi, Taniguchi, Yoshihiko, Saijo, Nobuhiko, Okishio, Kyoichi, Atagi, Shinji
Publicado 2020

Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave

por Kurahara, Yu, Kobayashi, Takehiko, Shintani, Sayoko, Matsuda, Yoshinobu, Tamiya, Akihiro, Sugawara, Reiko, Arai, Toru, Tachibana, Kazunobu, Okishio, Kyoichi, Matsui, Hideo, Tsuyuguchi, Kazunari
Publicado 2021

Retrospective analysis of long‐term survival factors in patients with advanced non‐small cell lung cancer treated with nivolumab

por Murakami, Yusuke, Tamiya, Akihiro, Taniguchi, Yoshihiko, Adachi, Yuichi, Enomoto, Takatoshi, Azuma, Koji, Inagaki, Yuji, Kouno, Shunichi, Matsuda, Yoshinobu, Okishio, Kyoichi, Atagi, Shinji
Publicado 2022

Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes

por Sato, Koichi, Akamatsu, Hiroaki, Koh, Yasuhiro, Ogawa, Koichi, Isa, Shun-ichi, Ando, Masahiko, Tamiya, Akihiro, Kubo, Akihito, Kitagawa, Chiyoe, Kawaguchi, Tomoya, Yamamoto, Nobuyuki
Publicado 2022

Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer

por Nakao, Keiko, Kobuchi, Shinji, Marutani, Shuhei, Iwazaki, Ayano, Tamiya, Akihiro, Isa, Shunichi, Okishio, Kyoichi, Kanazu, Masaki, Tamiya, Motohiro, Hirashima, Tomonori, Imai, Kimie, Sakaeda, Toshiyuki, Atagi, Shinji
Publicado 2019

Impact of docetaxel plus ramucirumab on metastatic site in previously treated patients with non-small cell lung cancer: a multicenter retrospective study

por Matsumoto, Kinnosuke, Tamiya, Akihiro, Matsuda, Yoshinobu, Taniguchi, Yoshihiko, Atagi, Shinji, Kawachi, Hayato, Tamiya, Motohiro, Tanizaki, Satoshi, Uchida, Junji, Ueno, Kiyonobu, Yanase, Takafumi, Suzuki, Hidekazu, Hirashima, Tomonori
Publicado 2021

Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer

por Shiroyama, Takayuki, Suzuki, Hidekazu, Tamiya, Motohiro, Tamiya, Akihiro, Tanaka, Ayako, Okamoto, Norio, Nakahama, Kenji, Taniguchi, Yoshihiko, Isa, Shun‐ichi, Inoue, Takako, Imamura, Fumio, Atagi, Shinji, Hirashima, Tomonori
Publicado 2017

Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer

por ISA, SHUN-ICHI, KURAHARA, YU, YAMAMOTO, SATOMI, TAMIYA, AKIHIRO, OMACHI, NAOKI, ASAMI, KAZUHIRO, OKISHIO, KYOICHI, UTSUMI, TOMOKI, ITO, NORIMASA, YOON, HYUNG-EUN, MATSUMURA, AKIHIDE, ATAGI, SHINJI, KAWAGUCHI, TOMOYA
Publicado 2015

Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab

por Morita, Mitsunori, Tamiya, Motohiro, Fujimoto, Daichi, Tamiya, Akihiro, Suzuki, Hidekazu, Hirano, Katsuya, Fukuda, Yasushi, Yokoyama, Toshihide, Kominami, Ryota, Kanazu, Masaki, Uchida, Junji, Hara, Satoshi, Yamashita, Shuji, Tomioka, Hiromi
Publicado 2020